Pasquale Cananzi
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The Sicilian Web plAtform for Rheumatology Network: complete regional implementation and first-year real-world drug utilisation.
Journal: Frontiers in digital health
Published: February 10, 2026
Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study.
Journal: Drug safety
Published: June 20, 2020
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 09, 2019
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010-2016.
Journal: BioMed research international
Published: September 26, 2019
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?
Journal: Pharmacoepidemiology and drug safety
Published: September 16, 2019
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.
Journal: Drug safety
Published: June 23, 2019
Antibiotic Consumption and Resistance during a 3-Year Period in Sicily, Southern Italy.
Journal: International journal of environmental research and public health
Published: May 27, 2019
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.
Journal: Expert opinion on drug safety
Published: May 07, 2019
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.
Journal: Frontiers in endocrinology
Published: December 14, 2017
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: May 04, 2016
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: July 15, 2015
How much are biosimilars used in southern Italy?: a retrospective analysis of epoetin utilization in the local health unit of Messina in the years 2010-2011.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: March 06, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026